Gilead Submits New Drug Application to U.S. FDA for Fixed-Dose Combo of Emtricitabine/Tenofovir Alafenamide for HIV Treatment
April 07, 2015 at 17:57 PM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug ...
